pentobarbital has been researched along with Marasmus in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Westhuysen, JM | 1 |
| Jones, JJ | 1 |
1 other study available for pentobarbital and Marasmus
| Article | Year |
|---|---|
Effect of protein energy malnutrition on the renal function and extracellular fluid volume of the rat.
Topics: Anesthesia; Angiotensin II; Animals; Blood Pressure; Chromium Isotopes; Diuresis; Edetic Acid; Extra | 1974 |